Attention Biotech Investors: Mark Your Calendar For August PDUFA Dates
The month of July was disappointing from the perspective of Food and Drug Administration decisions, as the agency handed down mostly negative verdicts.
AusCann, Flower One, Item 9 Labs & MariMed Among Top Cannabis Stock Movers On July 23, 2021
GAINERS:
Cann Gr (OTC: CNGGF) shares closed up 20.58% at $0.35
Bullish Sentiment Pumps Up Cannabis Stocks: Tilray, Sundial, Aurora & GrowGen Among Top Cannabis Movers For July 20, 2021
GAINERS:
Empower Clinics (OTC: EPWCF) shares closed up 18.43% at $0.39
A Complete List Of NYSE And NASDAQ-Listed Cannabis Companies (Updated)
As the cannabis industry keeps pushing forward, more companies are moving to list their stock on a major U.S. exchange like the NYSE or NASDAQ. The club, however, remains relatively small.
Cara Therapeutics Insights: Return On Capital Employed
During Q1, Cara Therapeutics (NASDAQ:CARA) brought in sales totaling $1.94 million. However, earnings decreased 130.09%, resulting in a loss of $23.56 million. Cara Therapeutics reached earnings of $78.29 million and sales of $112.09 million in Q4.
Cara Therapeutics Granted U.S. Patent Titled ‘Oral formulations of kappa opioid receptor agonists’
https://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&u=%2Fnetahtml%2FPTO%2Fsearch-adv.htm&r=6620&f=G&l=50&d=PTXT&p=133&S1=20210615&OS=20210615&RS=20210615
SWK Holdings Reports Its Wholly-Owned Subsidiary, Enteris BioPharma, Received $10M Milestone Payment From Cara Therapeutics For Licese Deal On Peptelligence Oral Formulation
SWK Holdings Corporation (NASDAQ:SWKH), a life sciences focused specialty finance company catering to small- and mid-sized commercial-stage companies, today announced that its wholly-owned subsidiary, Enteris BioPharma,
Cara Therapeutics: Return On Capital Employed Insights
During Q1, Cara Therapeutics (NASDAQ:CARA) brought in sales totaling $1.94 million. However, earnings decreased 130.09%, resulting in a loss of $23.56 million. Cara Therapeutics reached earnings of $78.29 million and sales of $112.09 million in Q4.
The Daily Biotech Pulse: Minerva, InflaRx Report Positive Data Readouts, Lucira COVID-19 Test Kit Available On Amazon, Decision Day For Heron
Here's a roundup of top developments in the biotech space over the last 24 hours.
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs May 11)
The Daily Biotech Pulse: FDA Authorizes Pfizer-BioNTech COVID-19 Vaccine For Adolescents, Lilly Strikes R&D Collaboration, Vaccine Stocks Novavax, Inovio Sink On Earnings
Here's a roundup of top developments in the biotech space over the last 24 hours:
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs May 10)